Current Protein Identity:P42260 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1S50 X-ray structure of the GluR6 ligand binding core (S1S2A) in complex with glutamate at 1.65 A resolution Deposited 2004-01-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 428–544(117 aa) Fragment:GluR6 ligand binding core
Chain A 665–806(142 aa) Fragment:GluR6 ligand binding core
Not recorded GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;24% PEG 4000 2 TRIS 20 NaCl 1 EDTA 10 NaGlu , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.65 Å R-free 0.230
1S7Y Crystal structure of the GluR6 ligand binding core in complex with glutamate at 1.75 A resolution orthorhombic form Deposited 2004-01-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–684(256 aa) Fragment:GluR6 S1S2
Chain B 429–684(256 aa) Fragment:GluR6 S1S2
Mutation:;1st Gly is vector encoded; remaining sequence corresponds to S398-K513 & P636-E755 of the mature GluR6 peptide joined by a vector encoded GT linker ; Mutation:;1st Gly is vector encoded; remaining sequence corresponds to S398-K513 & P636-E755 of the mature GluR6 peptide joined by a vector encoded GT linker ; GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.8;293 K;14% PEG 3350, 10 Citrate, 20 NaCl, 1 EDTA, 10 NaGlutamate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.75 Å R-free 0.243
1S9T Crystal structure of the GLUR6 ligand binding core in complex with quisqualate at 1.8A resolution Deposited 2004-02-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 1-259
Chain A 667–806(140 aa) Fragment:residues 1-259
Chain B 429–544(116 aa) Fragment:residues 1-259
Chain B 667–806(140 aa) Fragment:residues 1-259
Not recorded CL CHLORIDE ION × 4 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;14% PEG 3350, 50mM Malonate, 20mM NaCl, 1mM EDTA, 4.5mM Quisqualic acid, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.80 Å R-free 0.255
1SD3 Crystal structure of the GLUR6 ligand binding core in complex with 2S,4R-4-methylglutamate at 1.8 Angstrom resolution Deposited 2004-02-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 1-259
Chain A 667–806(140 aa) Fragment:residues 1-259
Chain B 429–544(116 aa) Fragment:residues 1-259
Chain B 667–806(140 aa) Fragment:residues 1-259
Not recorded SYM 2S,4R-4-METHYLGLUTAMATE × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.9;293 K;14% PEG 3350, 10mM malonate, 10mM BME, 20mM NaCl, 2mM Citrate, 1mM EDTA, 4.5mM 2S,4R-4-methylglutamate, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.80 Å R-free 0.256
1TT1 CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH KAINATE 1.93 A RESOLUTION Deposited 2004-06-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa)
Chain A 665–806(142 aa)
Chain B 429–544(116 aa)
Chain B 665–806(142 aa)
Not recorded KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions streak seeding;pH 4;297 K;18% PEG 3350, 25 mM Citrate, 2 mM Malonate, 20 mM NaCl, 1 mM EDTA, 10 mM BME, pH 4.0, streak seeding, temperature 297K
Resolution 1.93 Å R-free 0.216
2I0B Crystal structure of the GluR6 ligand binding core ELKQ mutant dimer at 1.96 Angstroms Resolution Deposited 2006-08-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 429–544(116 aa)
Chain A 667–806(140 aa)
Mutation:K494E, I749L, Q753K, E757Q Mutation:K494E, I749L, Q753K, E757Q GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.2;293 K;Reservoir: 1.5 M Ammonium Sulfate, 0.1 M NaCl, 0.1 M HEPES. 0.015 M Na Acetate; Protein: 12-22 mg/ml, 10 mM L-glutamate, 20 mM NaCl, 1 mM EDTA, pH 7.0, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.96 Å R-free 0.211
2I0B Crystal structure of the GluR6 ligand binding core ELKQ mutant dimer at 1.96 Angstroms Resolution Deposited 2006-08-10 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 429–544(116 aa)
Chain B 667–806(140 aa)
Chain C 429–544(116 aa)
Chain C 667–806(140 aa)
Mutation:K494E, I749L, Q753K, E757Q Mutation:K494E, I749L, Q753K, E757Q Mutation:K494E, I749L, Q753K, E757Q Mutation:K494E, I749L, Q753K, E757Q GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.2;293 K;Reservoir: 1.5 M Ammonium Sulfate, 0.1 M NaCl, 0.1 M HEPES. 0.015 M Na Acetate; Protein: 12-22 mg/ml, 10 mM L-glutamate, 20 mM NaCl, 1 mM EDTA, pH 7.0, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.96 Å R-free 0.211
2I0C Crystal structure of the GluR6 ligand binding core dimer crosslinked by disulfide bonds between Y490C and L752C at 2.25 Angstroms Resolution Deposited 2006-08-10 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa)
Chain A 667–806(140 aa)
Chain B 429–544(116 aa)
Chain B 667–806(140 aa)
Mutation:Y490C, L752C, S775E Mutation:Y490C, L752C, S775E Mutation:Y490C, L752C, S775E Mutation:Y490C, L752C, S775E GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;Reservoir: 20% isopropanol, 25% PEG 4k, 0.1 M NaCitrate. Protein: 7-15 mg/ml, 10 mM HEPES, 20 mM NaCl, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.25 Å R-free 0.244
2XXR Crystal structure of the GluK2 (GluR6) wild-type LBD dimer in complex with glutamate Deposited 2010-11-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Not recorded GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 1 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP. 27% PEG 4000, 3% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 1.60 Å R-free 0.195
2XXT Crystal structure of the GluK2 (GluR6) wild-type LBD dimer in complex with kainate Deposited 2010-11-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Not recorded KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 NA SODIUM ION × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 23% PEG 4000, 9% PROPAN-2-OL, 80MM SODIUM ACETATE.
Resolution 1.90 Å R-free 0.209
2XXU Crystal structure of the GluK2 (GluR6) M770K LBD dimer in complex with glutamate Deposited 2010-11-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 1 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP. 27% PEG 4000, 9% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 1.50 Å R-free 0.189
2XXV Crystal structure of the GluK2 (GluR6) M770K LBD dimer in complex with kainate Deposited 2010-11-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 27% PEG 4000, 6% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 1.70 Å R-free 0.203
2XXW Crystal structure of the GluK2 (GluR6) D776K LBD dimer in complex with glutamate Deposited 2010-11-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 21% PEG 4000, 80MM SODIUM ACETATE
Resolution 2.30 Å R-free 0.244
2XXX Crystal structure of the GluK2 (GluR6) D776K LBD dimer in complex with glutamate (P21 21 21) Deposited 2010-11-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 21% PEG 4000, 9% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 2.10 Å R-free 0.231
2XXX Crystal structure of the GluK2 (GluR6) D776K LBD dimer in complex with glutamate (P21 21 21) Deposited 2010-11-12 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain C 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 21% PEG 4000, 9% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 2.10 Å R-free 0.231
2XXY Crystal structure of the GluK2 (GluR6) D776K LBD dimer in complex with kainate Deposited 2010-11-12 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 21% PEG 4000, 3% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 3.00 Å R-free 0.264
2XXY Crystal structure of the GluK2 (GluR6) D776K LBD dimer in complex with kainate Deposited 2010-11-12 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain C 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP 21% PEG 4000, 3% PROPAN-2-OL, 80MM SODIUM ACETATE
Resolution 3.00 Å R-free 0.264
3G3F Crystal structure of the GluR6 ligand binding domain dimer with glutamate and NaCl at 1.38 Angstrom resolution Deposited 2009-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:residues 429-544, 667-806
Not recorded GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 1 NA SODIUM ION × 4 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;16% PEG4K, 12% isopropanol, 0.1M NaCitrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.38 Å R-free 0.175
3G3G Crystal structure of the GluR6 ligand binding domain dimer K665R mutant with glutamate and NaCl at 1.3 Angstrom resolution Deposited 2009-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:residues 429-544, 667-806
Mutation:K696R Mutation:K696R Mutation:K696R Mutation:K696R GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 3 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;15% PEG 4K, 13% ISOPROPANOL, 0.1 M NaCitrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.30 Å R-free 0.168
3G3H Crystal structure of the GluR6 ligand binding domain dimer K665R I749L Q753K mutant with glutamate and NaCl at 1.5 Angstrom resolution Deposited 2009-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:residues 429-544, 667-806
Mutation:K696R, I780L, Q784K Mutation:K696R, I780L, Q784K Mutation:K696R, I780L, Q784K Mutation:K696R, I780L, Q784K GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 2 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;15% PEG 4K, 13% ISOPROPANOL, 0.1 M NaCitrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.50 Å R-free 0.176
3G3I Crystal structure of the GluR6 ligand binding domain dimer I442H K494E I749L Q753K mutant with glutamate and NaCl at 1.37 Angstrom resolution Deposited 2009-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:residues 429-544, 667-806
Mutation:I473H, K525E, I780L, Q784K Mutation:I473H, K525E, I780L, Q784K Mutation:I473H, K525E, I780L, Q784K Mutation:I473H, K525E, I780L, Q784K GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 1 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG 4K, 13% ISOPROPANOL, 0.1 M NaCitrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.37 Å R-free 0.176
3G3J Crystal structure of the GluR6 ligand binding domain dimer I442H K494E K665R I749L Q753K mutant with glutamate and NaCl at 1.32 Angstrom resolution Deposited 2009-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:residues 429-544, 667-806
Mutation:I473H, K525E, K696R, I780L, Q784K Mutation:I473H, K525E, K696R, I780L, Q784K Mutation:I473H, K525E, K696R, I780L, Q784K Mutation:I473H, K525E, K696R, I780L, Q784K GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 2 NA SODIUM ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;15% PEG 4K, 15% ISOPROPANOL, 0.1 M NaCitrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.32 Å R-free 0.179
3G3K Crystal structure of the GluR6 ligand binding domain dimer I442H K494E K665R I749L Q753K E757Q mutant with glutamate and NaCl at 1.24 Angstrom resolution Deposited 2009-02-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:residues 429-544, 667-806
Mutation:I473H, K525E, K696R, I780L, Q784K, E788Q Mutation:I473H, K525E, K696R, I780L, Q784K, E788Q Mutation:I473H, K525E, K696R, I780L, Q784K, E788Q Mutation:I473H, K525E, K696R, I780L, Q784K, E788Q GLU GLUTAMIC ACID × 2 CL CHLORIDE ION × 5 NA SODIUM ION × 2 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;17% PEG 4K, 12% ISOPROPANOL, 0.1M NaCitrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.24 Å R-free 0.165
3H6G Crystal structure of the GluR6 amino terminal domain dimer assembly Deposited 2009-04-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 32–420(389 aa) Fragment:UNP residues 32-420
Chain B 32–420(389 aa) Fragment:UNP residues 32-420
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 TLA L(+)-TARTARIC ACID × 2 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;600 mM NaKTartrate, 200 mM NaCl, 20 mM NaAcetate, 1 mM EDTA, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.70 Å R-free 0.227
3H6H Crystal structure of the GluR6 amino terminal domain dimer assembly MPD form Deposited 2009-04-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 32–420(389 aa) Fragment:UNP residues 32-420
Chain B 32–420(389 aa) Fragment:UNP residues 32-420
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 9;293 K;100 mM Bicine, 10% MPD, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.90 Å R-free 0.254
3QLT Crystal structure of a GluK2 (GluR6) glycan wedge homodimer assembly Deposited 2011-02-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 32–420(389 aa)
Chain B 32–420(389 aa)
Mutation:A213N,G215S Mutation:A213N,G215S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;10% PEG 8K, 20% ethylene glycol, 0.02 M each 1,6-hexanediol, 1-butanol, (RS)-1,2-propanediol, 2-propanol, 1,4 butanediol, 1,3-propanediol, and 0.1 M MOPS/HEPES-Na, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.99 Å R-free 0.293
3QLU Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD dimer assembly Deposited 2011-02-03 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 32–420(389 aa)
Mutation:A213N,G215S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.2;293 K;0.15 M Ammonium Sulfate; 0.1 M Tris; 18% PEG 4K, pH 8.20, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.91 Å R-free 0.256
3QLU Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD dimer assembly Deposited 2011-02-03 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 32–420(389 aa)
Mutation:A213N,G215S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 CL CHLORIDE ION × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.2;293 K;0.15 M Ammonium Sulfate; 0.1 M Tris; 18% PEG 4K, pH 8.20, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.91 Å R-free 0.256
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 32–420(389 aa)
Chain D 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain F 32–420(389 aa)
Chain H 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 3 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain J 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 7 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain H 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
3QLV Crystal structure of the GluK2/GluK5 (GluR6/KA2) ATD tetramer assembly Deposited 2011-02-03 Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain J 32–420(389 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;293 K;10% Ethylene Glycol, 0.1 M HEPES, 5% PEG 8K, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 3.94 Å R-free 0.280
4BDL Crystal structure of the GluK2 K531A LBD dimer in complex with glutamate Deposited 2012-10-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 19% PEG 4,000, 3% PROPAN-2-OL, 80MM NA ACETATE
Resolution 1.75 Å R-free 0.202
4BDM Crystal structure of the GluK2 K531A LBD dimer in complex with kainate Deposited 2012-10-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 21% PEG 4,000, 9% PROPAN-2-OL, 80MM NA ACETATE
Resolution 3.40 Å R-free 0.289
4BDM Crystal structure of the GluK2 K531A LBD dimer in complex with kainate Deposited 2012-10-05 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain C 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 21% PEG 4,000, 9% PROPAN-2-OL, 80MM NA ACETATE
Resolution 3.40 Å R-free 0.289
4BDN Crystal structure of the GluK2 K531A-T779G LBD dimer in complex with glutamate Deposited 2012-10-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 25% PEG 4,000, 6% PROPAN-2-OL, 80MM NA ACETATE
Resolution 2.50 Å R-free 0.248
4BDN Crystal structure of the GluK2 K531A-T779G LBD dimer in complex with glutamate Deposited 2012-10-05 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain C 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 25% PEG 4,000, 6% PROPAN-2-OL, 80MM NA ACETATE
Resolution 2.50 Å R-free 0.248
4BDO Crystal structure of the GluK2 K531A-T779G LBD dimer in complex with kainate Deposited 2012-10-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 27% PEG 4,000, 6% PROPAN-2-OL, 80MM NA ACETATE
Resolution 2.55 Å R-free 0.241
4BDO Crystal structure of the GluK2 K531A-T779G LBD dimer in complex with kainate Deposited 2012-10-05 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain C 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain D 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 NA SODIUM ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 27% PEG 4,000, 6% PROPAN-2-OL, 80MM NA ACETATE
Resolution 2.55 Å R-free 0.241
4BDQ Crystal structure of the GluK2 R775A LBD dimer in complex with glutamate Deposited 2012-10-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 21% PEG 4,000, 80MM NA ACETATE
Resolution 1.90 Å R-free 0.213
4BDR Crystal structure of the GluK2 R775A LBD dimer in complex with kainate Deposited 2012-10-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain A 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 429–544(116 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Chain B 667–806(140 aa) Fragment:LIGAND BINDING DOMAIN, RESIDUES 429-544,667-806
Mutation:YES Mutation:YES Mutation:YES Mutation:YES KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 CL CHLORIDE ION × 1 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 23% PEG 4,000, 3% PROPAN-2-OL, 80MM NA ACETATE
Resolution 1.65 Å R-free 0.197
4H8I Structure of GluK2-LBD in complex with GluAzo Deposited 2012-09-22 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:SEE REMARK 999
Chain A 667–806(140 aa) Fragment:SEE REMARK 999
Chain B 429–544(116 aa) Fragment:SEE REMARK 999
Chain B 667–806(140 aa) Fragment:SEE REMARK 999
Not recorded 11W (4R)-4-[(2E)-3-{4-[(E)-phenyldiazenyl]phenyl}prop-2-en-1-yl]-L-glutamic acid × 1 CL CHLORIDE ION × 1 SO4 SULFATE ION × 1 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;2.05 M lithium sulfate, 10 mM magnesium chloride, 50 mM MES sodium, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.204
4UQQ Electron density map of GluK2 desensitized state in complex with 2S,4R-4-methylglutamate Deposited 2014-06-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 32–908(877 aa) Fragment:ATD LBD AND PARTIAL TMD, RESIDUES 32-908
Chain B 32–908(877 aa) Fragment:ATD LBD AND PARTIAL TMD, RESIDUES 32-908
Chain C 32–908(877 aa) Fragment:ATD LBD AND PARTIAL TMD, RESIDUES 32-908
Chain D 32–908(877 aa) Fragment:ATD LBD AND PARTIAL TMD, RESIDUES 32-908
Mutation:YES Mutation:YES Mutation:YES Mutation:YES GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer 150 MM NACL, 20 MM TRIS, 1 MM 2S,4R-4- METHYLGLUTAMATE, 0.75 MM DDM;pH 8;150 MM NACL, 20 MM TRIS, 1 MM 2S,4R-4- METHYLGLUTAMATE, 0.75 MM DDM
cryo-EM vitrification conditions Cryogen ETHANE;ETHANE
Resolution 7.60 Å
5CMK Crystal structure of the GluK2EM LBD dimer assembly complex with glutamate and LY466195 Deposited 2015-07-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa) Fragment:UNP residues 429-544, 667-806
Chain A 667–806(140 aa) Fragment:UNP residues 429-544, 667-806
Chain B 429–544(116 aa) Fragment:UNP residues 429-544, 667-806
Chain B 667–806(140 aa) Fragment:UNP residues 429-544, 667-806
Mutation:A487T A658S N690S F704L,A487T A658S N690S F704L Mutation:A487T A658S N690S F704L,A487T A658S N690S F704L Mutation:A487T A658S N690S F704L,A487T A658S N690S F704L Mutation:A487T A658S N690S F704L,A487T A658S N690S F704L GLU GLUTAMIC ACID × 1 LI LITHIUM ION × 2 CL CHLORIDE ION × 2 LY5 (3S,4aR,6S,8aR)-6-{[(2S)-2-carboxy-4,4-difluoropyrrolidin-1-yl]methyl}decahydroisoquinoline-3-carboxylic acid × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;291 K;Reservoir: 2M Li2SO4 3% PEG 4K 0.1M MgSO4 0.1 M NaAcetate Protein buffer: 100 mM NaCl, 5 mM LY466195, 1 mM EDTA, 10 mM HEPES pH 7 No added glutamate
Resolution 1.80 Å R-free 0.187
5CMM Crystal structure of the GluK2EM LBD dimer assembly complex with 2S,4R-4-methylglutamate Deposited 2015-07-16 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 429–544(116 aa) Fragment:UNP P42260 residues 429-544, UNP Q13002 residues 667-806
Mutation:A487T A658S N690S F704L,A487T A658S N690S F704L SYM 2S,4R-4-METHYLGLUTAMATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;291 K;Reservoir: 18% PEG 4K Protein buffer: 20 mM NaCl, 5 mM 2S,4R-4-methylglutamate, 1 mM EDTA, 2 mM TRIS pH 8
Resolution 1.27 Å R-free 0.163
5KUF GluK2EM with 2S,4R-4-methylglutamate Deposited 2016-07-13 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 32–908(877 aa)
Chain B 32–908(877 aa)
Chain C 32–908(877 aa)
Chain D 32–908(877 aa)
Not recorded SYM 2S,4R-4-METHYLGLUTAMATE × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
5KUH GluK2EM with LY466195 Deposited 2016-07-13 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 32–544(513 aa) Fragment:UNP residues 32-544,667-908
Chain A 667–908(242 aa) Fragment:UNP residues 32-544,667-908
Chain B 32–544(513 aa) Fragment:UNP residues 32-544,667-908
Chain B 667–908(242 aa) Fragment:UNP residues 32-544,667-908
Chain C 32–544(513 aa) Fragment:UNP residues 32-544,667-908
Chain C 667–908(242 aa) Fragment:UNP residues 32-544,667-908
Chain D 32–544(513 aa) Fragment:UNP residues 32-544,667-908
Chain D 667–908(242 aa) Fragment:UNP residues 32-544,667-908
Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F Mutation:T487A, S538A, S570N, L584F LY5 (3S,4aR,6S,8aR)-6-{[(2S)-2-carboxy-4,4-difluoropyrrolidin-1-yl]methyl}decahydroisoquinoline-3-carboxylic acid × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 11.60 Å
7F56 DNQX-bound GluK2-1xNeto2 complex, with asymmetric LBD Deposited 2021-06-21 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:F107L Mutation:F107L Mutation:F107L Mutation:F107L NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.10 Å
7F57 Kainate-bound GluK2-1xNeto2 complex, at the desensitized state Deposited 2021-06-21 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:F107L Mutation:F107L Mutation:F107L Mutation:F107L NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 11 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
7F59 DNQX-bound GluK2-1xNeto2 complex Deposited 2021-06-21 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:F107L Mutation:F107L Mutation:F107L Mutation:F107L NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 PGT (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.20 Å
7F5A DNQX-bound GluK2-2xNeto2 complex Deposited 2021-06-21 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:F107L Mutation:F107L Mutation:F107L Mutation:F107L NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 6.40 Å
7F5B LBD-TMD focused reconstruction of DNQX-bound GluK2-1xNeto2 complex Deposited 2021-06-21 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:F107L Mutation:F107L Mutation:F107L Mutation:F107L NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 CA CALCIUM ION × 1 PGT (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
7KS0 GluK2/K5 with 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) Deposited 2020-11-20 Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.30 Å
7KS3 GluK2/K5 with L-Glu Deposited 2020-11-20 Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.80 Å
8F0O cryo-EM structure of homomeric kainate receptor GluK2 in resting (apo) state Deposited 2022-11-03 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:I567V, C576V, C595S Mutation:I567V, C576V, C595S Mutation:I567V, C576V, C595S Mutation:I567V, C576V, C595S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.99 Å
8FWQ Structure of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 NA SODIUM ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.96 Å
8FWR Structure of the amino-terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
8FWS Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 NA SODIUM ION × 6 CL CHLORIDE ION × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.23 Å
8FWT Structure of the amino terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and competitive antagonist DNQX Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.09 Å
8FWU Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and competitive antagonist DNQX Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 NA SODIUM ION × 8 CL CHLORIDE ION × 2 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.18 Å
8FWV Structure of the amino-terminal domain of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and noncompetitive inhibitor perampanel Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.03 Å
8FWW Structure of the ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with the positive allosteric modulator BPAM344 and noncompetitive inhibitor perampanel Deposited 2023-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 6ZP 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile × 2 NA SODIUM ION × 7 CL CHLORIDE ION × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
8GC2 Domoate-bound GluK2 kainate receptor in partially-open conformation 1 Deposited 2023-03-01 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 34–908(875 aa)
Chain B 34–908(875 aa)
Chain C 34–908(875 aa)
Chain D 34–908(875 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 DOQ (2S,3S,4S)-2-CARBOXY-4-[(1Z,3E,5R)-5-CARBOXY-1-METHYL-1,3-HEXADIENYL]-3-PYRROLIDINEACETIC ACID × 3 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM Tris/HCl 150 mM NaCl 1mM DDM pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.10 Å
8GC3 Domote-bound GluK2 kainate receptors in partially-open conformation 2 Deposited 2023-03-01 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 34–908(875 aa)
Chain B 34–908(875 aa)
Chain C 34–908(875 aa)
Chain D 34–908(875 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 DOQ (2S,3S,4S)-2-CARBOXY-4-[(1Z,3E,5R)-5-CARBOXY-1-METHYL-1,3-HEXADIENYL]-3-PYRROLIDINEACETIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM Tris/HCl 150 mM NaCl 1mM DDM pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
8GC4 Domoate-bound GluK2 kainate receptor in partially-open conformation 3 Deposited 2023-03-01 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 34–908(875 aa)
Chain B 34–908(875 aa)
Chain C 34–908(875 aa)
Chain D 34–908(875 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 DOQ (2S,3S,4S)-2-CARBOXY-4-[(1Z,3E,5R)-5-CARBOXY-1-METHYL-1,3-HEXADIENYL]-3-PYRROLIDINEACETIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM Tris/HCl 150 mM NaCl 1mM DDM pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.93 Å
8GC5 Domoate-bound GluK2 kainate receptors in non-active conformation Deposited 2023-03-01 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 34–908(875 aa)
Chain B 34–908(875 aa)
Chain C 34–908(875 aa)
Chain D 34–908(875 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 DOQ (2S,3S,4S)-2-CARBOXY-4-[(1Z,3E,5R)-5-CARBOXY-1-METHYL-1,3-HEXADIENYL]-3-PYRROLIDINEACETIC ACID × 4 MAN alpha-D-mannopyranose × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM Tris/HCl 150 mM NaCl 1mM DDM pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.93 Å
8R32 Crystal structure of the GluK2 ligand-binding domain in complex with L-glutamate and BPAM344 at 1.60 A resolution Deposited 2023-11-08 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 429–544(116 aa)
Chain A 667–805(139 aa)
Not recorded GLU GLUTAMIC ACID × 2 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 CL CHLORIDE ION × 4 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;25% PEG4000, 9% propan-2-ol, 0.1 mM sodium acetate, pH 5.5
Resolution 1.60 Å R-free 0.178
8R32 Crystal structure of the GluK2 ligand-binding domain in complex with L-glutamate and BPAM344 at 1.60 A resolution Deposited 2023-11-08 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 429–544(116 aa)
Chain B 667–805(139 aa)
Not recorded GLU GLUTAMIC ACID × 2 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 CL CHLORIDE ION × 4 NA SODIUM ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;25% PEG4000, 9% propan-2-ol, 0.1 mM sodium acetate, pH 5.5
Resolution 1.60 Å R-free 0.178
9B35 Ligand-binding and transmembrane domains of kainate receptor GluK2 in the open state, a complex with agonist glutamate and positive allosteric modulator BPAM344 Deposited 2024-03-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
9B36 Open state of kainate receptor GluK2 in complex with agonist glutamate and positive allosteric modulator BPAM344 bound to two concanavalin A dimers. Composite map. Deposited 2024-03-18 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 GLU GLUTAMIC ACID × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 14 CLR CHOLESTEROL × 8 ZN ZINC ION × 4 CA CALCIUM ION × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.29 Å
9B37 Open state of kainate receptor GluK2 in complex with agonist glutamate and positive allosteric modulator BPAM344 bound to one concanavalin A dimer. Composite map. Deposited 2024-03-18 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 GLU GLUTAMIC ACID × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 14 CLR CHOLESTEROL × 8 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ZN ZINC ION × 2 CA CALCIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 6.66 Å
9B38 Kainate receptor GluK2 in complex with agonist glutamate with pseudo 4-fold symmetrical ligand-binding domain layer Deposited 2024-03-18 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded GLU GLUTAMIC ACID × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 MAN alpha-D-mannopyranose × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.36 Å
9B39 Kainate receptor GluK2 in complex with agonist glutamate with asymmetric ligand-binding domain layer Deposited 2024-03-18 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded GLU GLUTAMIC ACID × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 20 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.84 Å
9C5Y Structure of the amino-terminal domain of kainate receptor GluK2 in the apo state Deposited 2024-06-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen NITROGEN
Resolution 3.10 Å
9C5Z Structure of Ligand binding and transmembrane domains of kainate receptor Gluk2 in apo state Deposited 2024-06-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen NITROGEN
Resolution 3.63 Å
9C60 CryoEM structure of kainate receptor Gluk2 in apo state Deposited 2024-06-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen NITROGEN
Resolution 3.80 Å
9CAZ Structure of kainate receptor Gluk2 in apo state Deposited 2024-06-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 11 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen NITROGEN
Resolution 3.88 Å
9DXQ Ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with positive allosteric modulator BPAM-344 and channel blocker Philanthotoxin-74 Deposited 2024-10-11 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:I567V,Y571C Mutation:I567V,Y571C Mutation:I567V,Y571C Mutation:I567V,Y571C 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 CLR CHOLESTEROL × 8 NA SODIUM ION × 6 CL CHLORIDE ION × 2 A1BDR N-{7-[(4-aminobutyl)amino]heptyl}-Nalpha-butanoyl-D-tyrosinamide × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.81 Å
9DXR Ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with positive allosteric modulator BPAM-344 and channel blocker Nephilatoxin-8 Deposited 2024-10-11 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:I567V,Y571C Mutation:I567V,Y571C Mutation:I567V,Y571C Mutation:I567V,Y571C 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 A1BDS N~1~-{5-[(N-{4-[(3-aminopropyl)amino]butyl}-beta-alanyl)amino]pentyl}-N~2~-[(1H-indol-3-yl)acetyl]-D-aspartamide × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
9DXS Ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with positive allosteric modulator BPAM-344 and channel blocker Spermine Deposited 2024-10-11 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 12 CLR CHOLESTEROL × 8 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SPM SPERMINE × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.55 Å
9DXT Ligand-binding and transmembrane domains of kainate receptor GluK2 in complex with positive allosteric modulator BPAM-344 and channel blocker Kukoamine-A Deposited 2024-10-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 8 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 16 CLR CHOLESTEROL × 8 AH2 1-deoxy-alpha-D-mannopyranose × 4 A1BDT N,N'-[butane-1,4-diylbis(azanediylpropane-3,1-diyl)]bis[3-(3,4-dihydroxyphenyl)propanamide] × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.75 Å
9MZI CryoEM structure of GluK2 bound to glutamate in the deep desensitized state 3 Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 13 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.83 Å
9MZJ CryoEM structure of GluK2 bound to glutamate in the deep desensitized state 2 Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.74 Å
9MZK CryoEM structure of GluK2 bound to glutamate in the deep desensitized state 1 Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.81 Å
9MZL CryoEM structure of GluK2 bound to glutamate in the transition state Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.02 Å
9MZM CryoEM structure of GluK2 bound to glutamate in the shallow desensitized state, consensus map Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.86 Å
9MZN cryoEM structure of GluK2 ATD in the shallow desensitized state Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
9MZO cryoEM structure of GluK2 LBD-TMD bound to glutamate in the shallow desensitized state Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:N802C, K676C Mutation:N802C, K676C Mutation:N802C, K676C Mutation:N802C, K676C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.86 Å
9MZP CryoEM structure of GluK2 bound to glutamate in the shallow desensitized state, composite map Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
9MZR cryoEM structure of GluK2 LBD-TMD bound to BPAM344 and glutamate in the non-active state Deposited 2025-01-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Mutation:K676C, N802C Mutation:K676C, N802C Mutation:K676C, N802C Mutation:K676C, N802C 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.93 Å
9MZS cryoEM structure of GluK2 bound to BPAM344 and glutamate in the non-active state, composite map Deposited 2025-01-23 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 GLU GLUTAMIC ACID × 4 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
9N4L Composite map for GluK2 in the apo state with asymmetric ligand binding domain Deposited 2025-02-03 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.24 Å
9N4M Composite map for GluK2 in the apo state with 2-fold symmetrical ligand-binding domain Deposited 2025-02-03 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14 NA SODIUM ION × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.77 Å
9N4N Composite map for GluK2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate Deposited 2025-02-03 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.32 Å
9N4O Composite map for GluK2-0xNeto2 in the apo state with asymmetric ligand-binding domain Deposited 2025-02-03 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 15 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.60 Å
9N4P Composite map for GluK2-1xNeto2 in the apo state Deposited 2025-02-03 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 15 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.58 Å
9N4Q Composite map for GluK2-2xNeto2 in the apo state Deposited 2025-02-03 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 15 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.48 Å
9N4R Composite map for GluK2-0xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate Deposited 2025-02-03 Assembly 1 Other combination Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 20 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.48 Å
9N4S Composite map for GluK2-1xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate Deposited 2025-02-03 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 17 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 19 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.34 Å
9N4T Composite map for GluK2-2xNeto2 in the open state, in complex with the positive allosteric modulator BPAM344 and agonist kainate Deposited 2025-02-03 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 1–908(908 aa)
Chain B 1–908(908 aa)
Chain C 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 4 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 18 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 20 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.22 Å
9OSF The intact LBD state of GluK2/K5 with 5-iodowillardiine and kynurenic acid sodium salt Deposited 2025-05-24 Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris, 300 mM NaCl, 0.35 mM DDM, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.83 Å
9OSG The partially ruptured LBD state of GluK2/K5 with 5-iodowillardiine and kynurenic acid sodium salt Deposited 2025-05-24 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.83 Å
9OSI The intact LBD state of GluK2/K5 with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Deposited 2025-05-24 Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–908(908 aa)
Chain D 1–908(908 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris, 300 mM NaCl, 0.35 mM DDM, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.95 Å